Katia S. Fonseca

Ouro Preto, MG 35402133, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

In Vivo Trypanocidal Activity of the Drug Disulfiram Combined with Benznidazole.

In Vivo Trypanocidal Activity of the Drug Disulfiram Combined with Benznidazole.

Journal: ACS infectious diseases

Published: March 31, 2026

Influence of Chagas Disease on the Pharmacokinetics of Benznidazole in the Dog Model.

Influence of Chagas Disease on the Pharmacokinetics of Benznidazole in the Dog Model.

Journal: ACS pharmacology & translational science

Published: August 16, 2025

Anti-Trypanosoma cruzi Potential of Vestitol Isolated from Lyophilized Red Propolis.

Anti-Trypanosoma cruzi Potential of Vestitol Isolated from Lyophilized Red Propolis.

Journal: Molecules (Basel, Switzerland)

Published: August 30, 2023

Benznidazole, itraconazole, and their combination for the treatment of chronic experimental Chagas disease in dogs.

Benznidazole, itraconazole, and their combination for the treatment of chronic experimental Chagas disease in dogs.

Journal: Experimental parasitology

Published: January 22, 2022

Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain.

Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain.

Journal: Pathogens (Basel, Switzerland)

Published: April 10, 2021

Pharmacokinetics of Benznidazole in Experimental Chronic Chagas Disease Using the Swiss Mouse-Berenice-78 Trypanosoma cruzi Strain Model.

Pharmacokinetics of Benznidazole in Experimental Chronic Chagas Disease Using the Swiss Mouse-Berenice-78 Trypanosoma cruzi Strain Model.

Journal: Antimicrobial agents and chemotherapy

Published: June 30, 2020

Histopathological changes in the gastrointestinal tract and systemic alterations triggered by experimental oral infection with Trypanosoma cruzi.

Histopathological changes in the gastrointestinal tract and systemic alterations triggered by experimental oral infection with Trypanosoma cruzi.

Journal: Experimental parasitology

Published: May 06, 2020

Low-dose of benznidazole promotes therapeutic cure in experimental chronic Chagas' disease with absence of parasitism in blood, heart and colon.

Low-dose of benznidazole promotes therapeutic cure in experimental chronic Chagas' disease with absence of parasitism in blood, heart and colon.

Journal: Experimental parasitology

Published: November 05, 2019

Benznidazole, itraconazole and their combination in the treatment of acute experimental Chagas disease in dogs.

Benznidazole, itraconazole and their combination in the treatment of acute experimental Chagas disease in dogs.

Journal: MethodsX

Published: July 25, 2019

Benznidazole, itraconazole and their combination in the treatment of acute experimental chagas disease in dogs.

Benznidazole, itraconazole and their combination in the treatment of acute experimental chagas disease in dogs.

Journal: Experimental parasitology

Published: January 24, 2019

Design, synthesis, molecular modelling, and in vitro evaluation of tricyclic coumarins against Trypanosoma cruzi.

Design, synthesis, molecular modelling, and in vitro evaluation of tricyclic coumarins against Trypanosoma cruzi.

Journal: Chemical biology & drug design

Published: August 23, 2018

Pharmacokinetics and Tissue Distribution of Benznidazole after Oral Administration in Mice.

Pharmacokinetics and Tissue Distribution of Benznidazole after Oral Administration in Mice.

Journal: Antimicrobial agents and chemotherapy

Published: November 10, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026